Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease

IMPORTANCE: Low-dose methotrexate is used to treat rheumatoid arthritis and psoriasis. Due to its kidney elimination, better evidence is needed to inform its safety in adults with chronic kidney disease (CKD). OBJECTIVES: To compare the 90-day risk of serious adverse events among adults with CKD who...

Descripción completa

Detalles Bibliográficos
Autores principales: Muanda, Flory T., Blake, Peter G., Weir, Matthew A., Ahmadi, Fatemeh, McArthur, Eric, Sontrop, Jessica M., Urquhart, Brad L., Kim, Richard B., Garg, Amit X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682837/
https://www.ncbi.nlm.nih.gov/pubmed/38010652
http://dx.doi.org/10.1001/jamanetworkopen.2023.45132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682837/
https://www.ncbi.nlm.nih.gov/pubmed/38010652
http://dx.doi.org/10.1001/jamanetworkopen.2023.45132

Ejemplares similares